# Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation

> **NCT00936884** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 50 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** Methylnaltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00936884
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-01-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00936884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00936884, "Study Evaluating the Efficacy and Safety of Subcutaneous Methylnaltrexone (MOA-728) for the Treatment of Opioid-Induced-Constipation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00936884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*